- Report
- October 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
- Report
- May 2025
- 110 Pages
Global
From €4269EUR$4,750USD£3,744GBP
- Report
- June 2025
- 400 Pages
Global
From €4448EUR$4,949USD£3,901GBP
- Report
- June 2025
- 400 Pages
Global
From €4448EUR$4,949USD£3,901GBP
- Report
- June 2025
- 400 Pages
Global
From €4448EUR$4,949USD£3,901GBP
- Report
- August 2025
- 150 Pages
Global
From €3018EUR$3,358USD£2,647GBP
€3550EUR$3,950USD£3,114GBP
- Report
- June 2025
- 209 Pages
Global
From €4490EUR$4,995USD£3,937GBP
- Report
- February 2025
- 110 Pages
Global
From €3500EUR$4,171USD£3,177GBP
- Report
- October 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
- Report
- September 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
- Report
- July 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
€4359EUR$4,850USD£3,823GBP
- Report
- June 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
€4359EUR$4,850USD£3,823GBP
- Report
- June 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
€4359EUR$4,850USD£3,823GBP
- Report
- May 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
€4359EUR$4,850USD£3,823GBP
- Report
- February 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
€4359EUR$4,850USD£3,823GBP
- Report
- September 2025
- 480 Pages
Global
From €3236EUR$3,600USD£2,838GBP
- Newsletter
- November 2025
Global
€2692EUR$2,995USD£2,361GBP
- Report
- August 2025
- 115 Pages
Global
From €3101EUR$3,450USD£2,720GBP
- Report
- August 2025
- 205 Pages
Global
From €4449EUR$4,950USD£3,902GBP
- Report
- July 2025
- 295 Pages
Global
From €4490EUR$4,995USD£3,937GBP

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more